These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29176012)

  • 1. Sirolimus therapy for congenital hyperinsulinism in an infant with a novel homozygous KCNJ11 mutation.
    Korula S; Chapla A; Priyambada L; Mathai S; Simon A
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):87-89. PubMed ID: 29176012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus.
    Ünal S; Gönülal D; Uçaktürk A; Siyah Bilgin B; Flanagan SE; Gürbüz F; Tayfun M; Elmaoğulları S; Araslı A; Demirel F; Ellard S; Hussain K
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):478-481. PubMed ID: 27181099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus in the treatment of three infants with diffuse congenital hyperinsulinism.
    Al-Balwi R; Al-Atawi M; Al-Otaibi A; Babiker O; Al-Mutair A
    J Pediatr Endocrinol Metab; 2017 Aug; 30(9):1013-1017. PubMed ID: 28787272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent hyperinsulinemic hypoglycemia of infancy due to homozygous KCNJ11 (T294M) mutation.
    Ilamaran V; Venkatesh C; Manish K; Adhisivam B
    Indian J Pediatr; 2010 Jul; 77(7):803-4. PubMed ID: 20589481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Egyptian case of congenital hyperinsulinism of infancy due to a novel mutation in KCNJ11 encoding Kir6.2 and response to octreotide.
    Sherif EM; Abdelmaksoud AA; Elbarbary NS; Njølstad PR
    Acta Diabetol; 2013 Oct; 50(5):801-5. PubMed ID: 20686794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism.
    Bellanné-Chantelot C; Saint-Martin C; Ribeiro MJ; Vaury C; Verkarre V; Arnoux JB; Valayannopoulos V; Gobrecht S; Sempoux C; Rahier J; Fournet JC; Jaubert F; Aigrain Y; Nihoul-Fékété C; de Lonlay P
    J Med Genet; 2010 Nov; 47(11):752-9. PubMed ID: 20685672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to sirolimus in a case of diffuse congenital hyperinsulinaemic hypoglycaemia due to homozygous
    Oza CM; Khadilkar V; Kadam S; Khadilkar A
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36410788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
    Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L
    Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus Therapy and Follow-up in a Patient with Severe Congenital Hyperinsulinism Following Subtotal Pancreatectomy.
    Chen Q; Chen Y; Wang X; Yang H; Zhang Y; Liu X; Yan Y; Wei H
    J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):119-123. PubMed ID: 32482020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of a Long-Acting Somatostatin Analogue (Lanreotide) in Three Children with Focal Forms of Congenital Hyperinsulinaemic Hypoglycaemia.
    Dastamani A; Güemes M; Pitfield C; Morgan K; Rajab M; Rottenburger C; Bomanji J; De Coppi P; Dattani M; Shah P
    Horm Res Paediatr; 2019; 91(1):56-61. PubMed ID: 30114684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure due to somatostatin analog discontinuation in a case diagnosed as congenital hyperinsulinism novel mutation.
    Baş VN; Ozkan M; Zenciroğlu A; Cavuşoğlu YH; Cetinkaya S; Aycan Z
    J Pediatr Endocrinol Metab; 2012; 25(5-6):553-5. PubMed ID: 22876555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A syndrome of congenital hyperinsulinism and rhabdomyolysis is caused by KCNJ11 mutation.
    Albaqumi M; Alhabib FA; Shamseldin HE; Mohammed F; Alkuraya FS
    J Med Genet; 2014 Apr; 51(4):271-4. PubMed ID: 24421282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11.
    Hewat TI; Yau D; Jerome JCS; Laver TW; Houghton JAL; Shields BM; Flanagan SE; Patel KA
    Eur J Endocrinol; 2021 Oct; 185(6):813-818. PubMed ID: 34633981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia.
    Senniappan S; Alexandrescu S; Tatevian N; Shah P; Arya V; Flanagan S; Ellard S; Rampling D; Ashworth M; Brown RE; Hussain K
    N Engl J Med; 2014 Mar; 370(12):1131-7. PubMed ID: 24645945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures.
    Darendeliler F; Fournet JC; Baş F; Junien C; Gross MS; Bundak R; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 2002; 15(7):993-1000. PubMed ID: 12199344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital hyperinsulinism in newborn and infant].
    Giurgea I; Ribeiro MJ; Boddaert N; Touati G; Robert JJ; Saudubray JM; Jaubert F; Bellanné-Chantelot C; Brunelle F; Nihoul-Fékété C; de Lonlay P
    Arch Pediatr; 2005 Nov; 12(11):1628-35. PubMed ID: 16198094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks.
    Kumaran A; Kapoor RR; Flanagan SE; Ellard S; Hussain K
    Horm Res Paediatr; 2010; 73(4):287-92. PubMed ID: 20215776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial ABCC8 gene deletion mutations causing diazoxide-unresponsive hyperinsulinaemic hypoglycaemia.
    Flanagan S; Damhuis A; Banerjee I; Rokicki D; Jefferies C; Kapoor R; Hussain K; Ellard S
    Pediatr Diabetes; 2012 May; 13(3):285-9. PubMed ID: 21978130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism.
    Banerjee I; Skae M; Flanagan SE; Rigby L; Patel L; Didi M; Blair J; Ehtisham S; Ellard S; Cosgrove KE; Dunne MJ; Clayton PE
    Eur J Endocrinol; 2011 May; 164(5):733-40. PubMed ID: 21378087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of recessive and dominant congenital hyperinsulinism due to mutation(s) in the ABCC8/KCNJ11 genes encoding the ATP-sensitive potasium channel in the pancreatic beta cell.
    Oçal G; Flanagan SE; Hacihamdioğlu B; Berberoğlu M; Siklar Z; Ellard S; Savas Erdeve S; Okulu E; Akin IM; Atasay B; Arsan S; Yağmurlu A
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1019-23. PubMed ID: 22308858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.